Fibro Foundation

"I know there is a cure out there and I hope we find it in my lifetime, 
but if we don't... you have to find it."
                                                              - Tucker Davis 1981-2010

Newly diagnosed? Click here.

In 2008, when Tucker Davis (age 26) was diagnosed with fibrolamellar hepatocellular carcinoma (FHC), he founded the Fibrolamellar Cancer Foundation (FCF) with the hope of finding a cure for this often fatal disease. Because the incidence of FHC was so rare, little research had been conducted at that time. FCF has helped change that.

FCF's mission is three-fold:

  1. Find a cure and treatment options

  2. Raise awareness of this disease

  3. Connect and support the fibrolamellar community of patients and their families

FCF is an IRS approved 501 (c) (3) tax deductible public charity. 100% of net donations go towards research. All FCF's overhead and administrative costs are paid by the Charles A. and Marna Davis Foundation and Stone Point Capital.

~~~~ Featured Ambassador Family ~~~~

Cheers To Jay

This event was to commemorate three years since Jay Alexander's passing. It was held November 13, 2014 at Brick Street Brews in Arkansas.  $2,055.80 was raised for the Fibrolamellar Cancer Foundation from the event. Shelia, Greg, and Brooke Alexander were the guest bartenders and they packed the house! Brick Street Brews serves local craft beers and wines; they donated $1 per drink to FCF.  The "bartenders" (pictured to the right) donated all the tips.  What a wonderful event! 

This is only the latest event organized by the 
Alexander family since Jay's passing.   A "Jumping for Jay" skydiving event happened the year after Jay's passing, Brooke ran in the NYC marathon, and a friend of the Alexander's ran multiple marathons raising significant funds for FCF.

Thank you Alexanders for all you do for FCF!

Previously Featured Ambassador stories archived here.

Photos in header:  (Above, left) Tucker Davis, (Above, right) Joshua Honeyman, former Rockefeller University Fellow, at work in Dr. Simon’s research lab in NYC